stars 1 stars 2 stars 3

Virscio is a translational research organization providing in vivo NHP safety and disease modeling and related preclinical research and development services, including histopathology in all species. We specialize in the fields of central nervous system, ophthalmology, cardiovascular, metabolic and dermatologic diseases, and have advanced preclinical toxicology and efficacy programs for sponsors around the world. We work with pharmaceutical and biotechnology companies, and consultants and academic teams to reduce development risk and define the most effective path to value inflection and clinic.

Virscio Questions

The Virscio annual revenue was $16.8 million in 2026.

Matthew Lawrence is the CEO and CSO of Virscio.

39 people are employed at Virscio.

Virscio is based in New Haven, Connecticut.

The NAICS codes for Virscio are [54171, 541, 54, 541714, 5417].

The SIC codes for Virscio are [87, 873].

Top Virscio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users